PVX-4

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NamePVX-4
Drug Alias NamepBI-4 DNA vaccine (Papivax Biotech)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPapivax Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesPapivax Biotech Inc
Inactive CompaniesN/A
Active IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A